Evidence map›Paper›PMID 35966335›Full record

ArticleMediators of inflammation2022

HMGA2 Promotes Brain Injury in Rats with Cerebral Infarction by Activating TLR4/NF-

Shaoyue Huang, Zhen Hong, Leguo Zhang, Jian Guo, Yanhua Li, Kuo Li

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Observational
  3. The emerging role and mechanism of HMGA2 in breast cancer.Journal of cancer research and clinical oncology · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shaoyue HuangNo. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Zhen HongNo. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Leguo ZhangNo. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Jian GuoNo. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Yanhua LiNo. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.
Kuo LiNo. 2 Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei, China.ORCID https://orcid.org/0000-0001-7611-116X
Cangzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral infarction is a common disease with a higher disability and fatality rates. The incidence rates of cerebral infarction or cerebral ischemic stroke gradually increase with aging and cerebrovascular disease progression. This study is aimed at evaluating the effects of HMGA2 on cerebral infarction-induced brain tissue damage and its underlying mechanisms. Adult Sprague Dawley rats were pretreated with sh-HMGA2 before cerebral infarction operation. The effect of HMGA2 on the arrangement, distribution, and morphological structure of neurons and the cell apoptosis ratio in brain tissue were detected via hematoxylin and eosin staining, brain-water content, TTC staining, and TUNEL staining. The results from ELISA assay, qPCR, and western blot indicated that downregulation of HMGA2 mitigated inflammatory stress via regulating the expression of TLR4/NF-

Indexed as

Brain InjuriesBrain IschemiaNeuroprotective AgentsStrokeAnimalsCerebral InfarctionHMGA2 ProteinHMGB2 ProteinNF-kappa BRatsRats, Sprague-DawleySignal TransductionToll-Like Receptor 4HMGA2 ProteinHMGA2 protein, ratHMGB2 ProteinNeuroprotective AgentsNF-kappa BTlr4 protein, ratToll-Like Receptor 4

Identifiers

PMID35966335
PMCPMC9371803
OpenAlexW4289779299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.